Literature DB >> 26248838

Surgery versus SABR for resectable non-small-cell lung cancer.

Isabelle Opitz1, Gaetano Rocco2, Alessandro Brunelli3, Gonzalo Varela4, Gilbert Massard5, Walter Weder6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26248838     DOI： 10.1016/S1470-2045(15)00123-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

2.  Stage I lung cancer-to operate or to radiate? that is the question.

Authors:  Boris Sepesi; David C Rice; John V Heymach; Ara A Vaporciyan; Stephen G Swisher
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 3.  Salvage surgery after high-dose radiotherapy.

Authors:  Annemie Van Breussegem; Jeroen M Hendriks; Patrick Lauwers; Paul E Van Schil
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

4.  Surgery compared to stereotactic body radiation therapy for early-stage non-small cell lung cancer: better, equivalent or worse?

Authors:  Paul E Van Schil
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.